Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Src homology 2 domain containing (SHC) is a proto-oncogene which mediates cell proliferation and carcinogenesis in human carcinomas. Here, the
SHC SH2-domain binding protein 1
(
SHCBP1
) was first established to be up-regulated in human
hepatocellular carcinoma
(
HCC
) tissues by array-base comparative genome hybridization (aCGH). Meanwhile, we examine and verify it by quantitative real-time PCR and western blot. Our current data show that
SHCBP1
was up-regulated in
HCC
tissues. Overexpression of
SHCBP1
could significantly promote
HCC
cell proliferation, survival and colony formation in
HCC
cell lines. Furthermore, knockdown of
SHCBP1
induced cell cycle delay and suppressed cell proliferation. Furthermore,
SHCBP1
could regulate the expression of activate extracellular signal-regulated kinase 1/2 (ERK1/2) and cyclin D1. Together, our findings indicate that
SHCBP1
may contribute to human
hepatocellular carcinoma
by promoting cell proliferation and may serve as a molecular target of cancer therapy.
...
PMID:Targeting SHCBP1 inhibits cell proliferation in human hepatocellular carcinoma cells. 2428 56